DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 30 Yrs Exp. in the feld of Organic Chemistry. Serving chemists around the world. Helping them with websites on Chemistry.Millions of hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
n

Thursday, 27 June 2013

A molecular database for developing organic solar cells


molecular_space_logo




Harvard researchers have released a massive database of more than 2 million molecules that might be useful in the construction of solar cells that rely on organic compounds for construction of organic solar cells for the production of renewable energy. Developed as part of the Materials Genome Initiative launched by the White House’s Office of … more…

http://www.kurzweilai.net/a-molecular-database-for-developing-organic-solar-cells?utm_source=KurzweilAI+Daily+Newsletter&utm_campaign=4fc1bf53a4-UA-946742-1&utm_medium=email&utm_term=0_6de721fb33-4fc1bf53a4-282116853





Monday, 24 June 2013

Lab Reproduction of Marine Compound with Antibiotic Properties




 
Baringolin is a marine product with antibiotic properties. Image: IRB Barcelona
 

Barcelona, Spain (Scicasts) – Bacterial resistance to drugs leads pharmaceutical labs to be in constant search for new antibiotics to treat the same diseases. For the last thirty years, the sea bottom has yielded a wealth of substances with properties of interest to the pharmaceutical industry.
 
Isolated from a marine microorganism off the coast of Alicante by the company BioMar, baringolin shows promising antibiotic activity at a very low concentration. The Combinatorial Lab headed by Fernando Albericio at the Institute for Research in Biomedicine (IRB Barcelona), which collaborates with BioMar, has now synthesized this molecule and revealed its structure. Today's results open up the possibility to better understand how this substance works and to design derivatives to turn into a viable drug in the next 10 years. These findings are published in todays' online edition of the journal Angewandte Chemie.

read all at

http://scicasts.com/bioit/1858-drug-development/6186-lab-reproduction-of-marine-compound-with-antibiotic-properties

From left to right, this image shows researchers Mercedes Alvárez, Xavier Just-Baringo and Fernando Albericio from the IRB Barcelona.
(Photo Credit: IRB Barcelona)


/files/Image/XavierJust.jpg

Xavier Just, PhD student at IRB Barcelona, has reproduced the natural structure in the lab

 Reference article:
Total Synthesis and Stereochemical Assignment of Baringolin
Xavier Just-Baringo, Paolo Bruno, Lars K. Ottesen, Librada M. Cañedo, Fernando Albericio and Mercedes Álvarez.
Angewandte Chemie (2013) http://dx.doi.org/10.1002/ange.201302372 (German Edition) http://dx.doi.org/10.1002/anie.201302372 (International Edition)



Natural Products from St. John's Wort


Natural Products from St. John's Wort

Enatiomers (−)-hyperione A and (−)-hyperione B can be synthesised from a common precursor in ten steps
Read more


http://www.chemistryviews.org/details/ezine/1238795/Natural_Products_from_St__Johns_Wort.html



doc b's CV

Tuesday, 11 June 2013

Bruce Roth Awarded 2013 Perkin Medal


Bruce Roth
Roth
Credit: Genentech

Bruce Roth Awarded 2013 Perkin Medal

Honors: Chemist was the first to synthesize the cholesterol-lowering drug atorvastatin, also known as Lipitor
The Society of Chemical Industry (SCI) has selected Bruce D. Roth, vice president of discovery chemistry at Genentech, as the winner of the 2013 Perkin Medal. The annual award is recognized as the highest honor given for outstanding work in applied chemistry in the U.S.
http://cen.acs.org/articles/91/web/2013/06/Bruce-Roth-Awarded-2013-Perkin.html